Featured Research

from universities, journals, and other organizations

Women and PAD: Excellent treatment outcomes in spite of disease severity

Date:
May 5, 2014
Source:
University of Michigan Health System
Summary:
Stakes are higher for women with PAD, a circulation issue that's common among older adults. But women benefit just as much as men from procedures to unclog arteries. A new study demonstrates the need for doctors to ask women about leg discomfort and to screen for peripheral artery disease. PAD happens when fatty deposits build up in arteries outside the heart, usually the arteries supplying fresh oxygen and blood to the arms, legs and feet.

Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral artery disease (PAD), but minimally invasive procedures used to unclog arteries are just as successful as in men.

Related Articles


The success of procedures, such as angioplasty or stent placement, in treating women with leg PAD was revealed in a Journal of the American College of Cardiology study. The study provides a rare look at gender differences in PAD.

PAD happens when fatty deposits build up in arteries outside the heart, usually the arteries supplying fresh oxygen and blood to the arms, legs and feet.

About 8 million Americans have peripheral artery disease, but PAD awareness among men and women is strikingly low compared with other cardiovascular diseases like hypertension and heart attacks.

"We found that women had excellent outcomes compared to men, even though they were older and had more severe disease," says senior study author P. Michael Grossman, M.D., an interventional cardiologist at the University of Michigan Frankel Cardiovascular Center and director of the cardiac catheterization laboratory at the Veterans Administration Ann Arbor Healthcare System.

Before treatment, women were at higher risk of amputation, and more likely to suffer from leg pain at rest or ulceration, called critical limb ischemia.

Fewer women complained of leg discomfort, fatigue or cramping with activity known as claudication, according to the study.

"The reasons for differences in symptoms are unclear, and deserve further study. It does indicate that we need to be vigilant in asking women about leg discomfort and screening women for PAD," says Grossman.

Researchers used Michigan's Blue Cross Blue Shield of Michigan Cardiovascular Consortium PVI registry, which collected data from 16 Michigan hospitals about percutaneous peripheral vascular intervention.

A total of 12,379 patients had lower extremity PVI from 2004 to 2009, and the overall procedural success rate of PVI was 79 percent for women compared to 81 percent for men. There was also no difference in heart attacks or strokes.

It was surprising, researchers say, to observe no gender-related differences in procedural success considering that women experienced more transfusions, vascular complications and embolisms.

"The data suggests women may benefit to a greater degree with an invasive percutaneous strategy for the management of PAD, particularly if complications can be avoided," says study author Elizabeth Jackson, M.D., cardiologist and director of the University of Michigan Women's Heart Program.

According to the study, women were less likely than men to be prescribed cholesterol-lowering statins and antiplatelet therapy before the procedure.

"More could be done to ensure all patients with PAD are prescribed these medications, particularly women," Jackson says.

Some patients need minimally invasive procedures to unclog arteries and restore blood flow, but lifestyle changes, such as quitting smoking, exercise and medications are known to slow or even reverse the symptoms of PAD.


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Elizabeth A. Jackson, Khan Munir, Theodore Schreiber, Jeffrey R. Rubin, Robert Cuff, Katherine A. Gallagher, Peter K. Henke, Hitinder S. Gurm, P. Michael Grossman. Impact of Gender on Morbidity and Mortality Rates Following Lower Extremity Interventions for Peripheral Arterial Disease: Observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Journal of the American College of Cardiology, 2014; DOI: 10.1016/j.jacc.2014.03.036

Cite This Page:

University of Michigan Health System. "Women and PAD: Excellent treatment outcomes in spite of disease severity." ScienceDaily. ScienceDaily, 5 May 2014. <www.sciencedaily.com/releases/2014/05/140505104353.htm>.
University of Michigan Health System. (2014, May 5). Women and PAD: Excellent treatment outcomes in spite of disease severity. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2014/05/140505104353.htm
University of Michigan Health System. "Women and PAD: Excellent treatment outcomes in spite of disease severity." ScienceDaily. www.sciencedaily.com/releases/2014/05/140505104353.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins